MediaCom

ResMed Announces Its Premier Portable Oxygen Concentrator, Mobi

SAN FRANCISCO, Jan. 9, 2018 /PRNewswire-AsiaNet/ --

-- Mobi helps oxygen patients embrace active, healthy lifestyles

ResMed (NYSE: RMD, ASX: RMD) today introduced Mobi, its first ResMed-branded 
portable oxygen concentrator (POC).

Mobi offers an industry-leading balance of oxygen delivery, weight and battery 
life so that millions with chronic obstructive pulmonary disease (COPD) or 
other respiratory condition can enjoy ResMed-quality oxygen therapy at home or 
on the go.

"We have focused decades of patient-centered ResMed technology and design 
innovation into this POC," said ResMed CEO Mick Farrell. "We've achieved great 
mobility, comfort and therapy quality in sleep apnea treatment with AirMini, 
the world's smallest PAP device. Mobi offers that same great balance to the 
many millions of people who rely on supplemental oxygen to enjoy their highest 
quality of life."

Mobility is particularly key for oxygen patients with chronic obstructive 
pulmonary disease. Regular physical activity is shown to lower the risk of 
hospitalization and death among those with COPD, according to a 2006 study 
published in Thorax: http://thorax.bmj.com/content/61/9/772.

"The time is now for portable oxygen," said Farrell. "Our patients demand a 
device that enables them to get out of their house and travel to visit friends 
and family. Mobi gives the gift of freedom to millions."

Availability

Mobi will be available to U.S. patients through their home medical equipment 
(HME) providers later this quarter. ResMed is pursuing clearance to sell in 
other countries in 2018.

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with 
more than 4 million cloud-connected devices for daily remote patient 
monitoring, changes lives with every breath. Its award-winning devices and 
software solutions help treat and manage sleep apnea, chronic obstructive 
pulmonary disease and other respiratory conditions. Its 6,000-member team 
strives to improve patients' quality of life, reduce the impact of chronic 
disease and save healthcare costs in more than 120 countries. www.ResMed.com

For media: 
Jayme Rubenstein 
+1 858-836-6798 
news@resmed.com 

For investors: 
Agnes Lee 
+1 858-836-5971 
investorrelations@resmed.com  

Logo - https://mma.prnewswire.com/media/181637/resmed_inc__logo.jpg 

SOURCE: ResMed Inc.